Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer
1993

Chromosome 11q Changes in Ovarian Cancer

Sample size: 28 publication Evidence: moderate

Author Information

Author(s): W.D. Foulkes, I.G. Campbell, G.W.H. Stamp, J. Trowsdale

Primary Institution: Imperial Cancer Research Fund and Royal Postgraduate Medical School

Hypothesis

What genetic alterations on chromosome 11q contribute to ovarian carcinogenesis?

Conclusion

The study found significant loss of heterozygosity and amplification on chromosome 11q in ovarian cancer, suggesting the presence of a tumor suppressor gene in this region.

Supporting Evidence

  • Over 80% of nonmucinous epithelial ovarian cancers express high levels of the folate receptor.
  • Four out of 28 cancers showed amplification of the 11q13 region.
  • Significant loss of heterozygosity was found at 11q23.3-qter in 67% of cases.

Takeaway

Scientists looked at DNA from ovarian cancer patients and found changes in a specific part of their chromosomes that might help explain how the cancer develops.

Methodology

The study used Southern blotting and PCR techniques to analyze tumor and lymphocyte DNA from patients.

Limitations

The study had a small sample size and may not represent all ovarian cancer cases.

Participant Demographics

Patients were unselected and operated on at various hospitals in London.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication